3D189
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 3D189, covering 2025-05-29 to 2025-05-29. Get the full timeline:
Most recent: Clinical Trial Update: Study of 3D189 in Patients With Hematologic Malignancies [Phase 1]